NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

If according to Senti and Hyperopia, the submission of the MAA was
delayed so that the MAA approval was delayed to occur a number
of months prior to the approval of the Flaskworks process, why was the
MAA submission not even further delayed so that it would coincide with
the flaskworks process approval?

What is the point of having a gap of few months between those two
approvals if that time gap ( a number of months) would not be sufficient
for NICE and NWBO to agree on a reimbursement sum for the artisan
treatment and for said treatment to be utilized before it is replaced
by the Flaskworks methodology?

Seems to me that kind of delay in the MAA submission would have simply
harmed patients who could have benefited from the artisan manufactured
vaccine but due to the delay could potentially miss the lifesaving boat.